Skip to content

Niemann Pick Disease Type C1 Juvenile Form C4017106

Published: July 22, 2026Updated: August 25, 2026

A juvenile-onset form of NPC1-related cholesterol storage disorder. Causes progressive movement problems, cognitive decline, and organ involvement. Care is primarily supportive.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue or weight changes

(metabolic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Psychomotor regression

(neurological)

Dysarthria

(neurological)

Dystonia

(neurological)

Hearing loss

(ENT)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Evidence-based pharmacological treatment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Miglustat therapy

Enzyme inhibitor therapy that reduces accumulation of glycolipids in cells by inhibiting glucosylceramide synthase. This is the primary disease-modifying treatment for Niemann-Pick type C1.

medication
3

Comprehensive neurological monitoring

Regular assessment of neurological function including cognitive testing, motor evaluation, and neuroimaging to track disease progression and treatment response.

monitoring

Additional treatment options

Adaptive physical therapy

Individualized exercise program focusing on maintaining joint mobility, balance training, and functional movement to preserve motor abilities as disease progresses.

physical_therapy

Low-fat nutritional support

Dietary modification to reduce fat absorption burden and manage hepatosplenomegaly symptoms, often including medium-chain triglyceride supplementation.

dietary

Neuropsychological support services

Cognitive rehabilitation and psychological support addressing memory difficulties, behavioral changes, and emotional adjustment for both patient and family members.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Niemann Pick Disease Type C1 Juvenile Form C4017106?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Niemann Pick Disease Type C1 Juvenile Form C4017106. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy